Novel mutation in KIF23 causing congenital dyserythropoietic anemia type III in patients who underwent allogeneic hematopoietic stem cell transplantation

Pediatr Blood Cancer. 2024 Jun;71(6):e30736. doi: 10.1002/pbc.30736. Epub 2024 Mar 24.

Authors

Tomoko Fujikawa¹, Suguru Uemura¹, Daiichiro Hasegawa¹, Naoya Morisada², Sayaka Nakamura¹, Aiko Kozaki¹, Atsuro Saito¹, Kenji Kishimoto¹, Toshiaki Ishida¹, Takeshi Mori¹, Kimikazu Yakushijin³, Yoshio Katayama⁴, Daiki Yamashita⁵, Manabu Wakamatsu⁵, Motoharu Hamada⁵, Hideki Muramatsu⁵, Yoshiyuki Takahashi⁵, Yoshiyuki Kosaka¹

Affiliations

¹ Department of Hematology and Oncology, Kobe Children's Hospital, Kobe, Japan.
² Department of Clinical Genetics, Kobe Children's Hospital, Kobe, Japan.
³ Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan.
⁴ Hematology, Kobe University Hospital, Kobe, Japan.
⁵ Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

PMID: 38523246
DOI: 10.1002/pbc.30736

No abstract available

Publication types

Letter
Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Anemia, Dyserythropoietic, Congenital* / genetics
Child
Child, Preschool
Female
Hematopoietic Stem Cell Transplantation*
Humans
Infant
Kinesins* / genetics
Male
Mutation*
Transplantation, Homologous

Substances

Kinesins